Wednesday , December 13 2017
Home / Resources / Videos / Stanley Schwartz, MD: Preventing Hypoglycemia in the Hospital Using Incretins

Stanley Schwartz, MD: Preventing Hypoglycemia in the Hospital Using Incretins

Stanely_Schwartz_MD

Dr. Schwartz describes how he helped to develop an intensive insulin regimen to decrease the incidence of hypoglycemia in hospitals but found that the strategy was not as effective as hoped. Incretins were then introduced to help control hypoglycemia and have since proved highly effective, and Dr. Schwartz outlines the details of this method….

 

More videos with Dr. Schwartz:

Stanley Schwartz, MD, Introduction

Tips for Maximizing Medication Effectiveness and Patient Health

How Exercise Fits In with Diabetes Control

What Is the Best A1c?

Stanley Schwartz, MD, has been awarded the honor of being a TOP DOC by Philadelphia Magazine many times over the years, including 2009, 2010 and 2011 for the treatment of diabetes and metabolic syndrome. For over 30 years, Dr. Schwartz was an Associate Professor at the University of Pennsylvania, most recently directing the Diabetes Program at the Philadelphia Heart Institute. Dr. Stanley Schwartz is a new Affiliate of the Main Line Health System, and an Emeritus Associate Professor of Medicine at the University of Pennsylvania, currently in a private practice in Ardmore, Pa. Dr. Schwartz received his MD in 1973 from the University of Chicago in Chicago, Illinois. He then completed his residency at the University of Pennsylvania, followed by a fellowship in endocrinology and metabolism at the University of Chicago.
Dr. Schwartz serves on the following Advisory Boards: Eli Lilly, Inc.; Amylin Pharmaceuticals; Takeda; Janssen; sanofi-aventis; and Santarus
He is also part of the following speaker’s bureaus: Merck; Eli Lilly;  Amylin Pharmaceuticals; Takeda; Santarus; BMS; Astra-Zeneca; and Novo Novartis.
Diabetes In Control is honored to also have Dr. Schwartz on our Advisory Board as well as a contributor to our newsletters.